Back to top

Insulet’s EVOLUTION T1D Trial Signals Next Step in Automated Insulin Delivery

Insulet ($PODD) announced an update on their ongoing clinical study. Insulet (PODD) is running the EVOLUTION T1D study to test a new insulin delive...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Insulet Corporation (PODD)